Enter assignee name

EPO Patents = 5

Trademarks = 2

Forward Citations = 14

Loading Chart...

12 inventors (with patents filed for the assignee):

Kevin Koch (7 out of 42 patents)

Alan Russell (7 out of 9 patents)

Stephen T Schlachter (7 out of 49 patents)

4. Kevin W Hunt (7 out of 23 patents)

5. Paul Winship (5 out of 7 patents)

6. Chris Steele (5 out of 7 patents)

7. Grace Uzoho (2 out of 4 patents)

8. Michael Luzzio (2 out of 51 patents)

9. Natalie Anne Hawryluk (2 out of 2 patents)

10. Marc Justin Evanchik (2 out of 2 patents)

11. Carlos Luis Del Rio (2 out of 2 patents)

12. Michael Mark DuVall (1 out of 1 patent)

13. Grace Uzoho (0 patent)

14. Paul Winship (0 patent)

15. Chris Steele (0 patent)

7 patents: Sort by Forward Citations

1. 12509431 - 1,4-dihydroquinazolinone compounds and uses thereof (2025-12-30),

2. 12448369 - Quinolinone amide compounds and uses thereof (2025-10-21),

3. 12415794 - Pyridazinone compounds and uses thereof (2025-09-16),

4. 12240833 - Pyridazinone compounds and uses thereof (2025-03-04),

5. 12240831 - Pyridazinone compounds and uses thereof (2025-03-04),

6. 12012395 - Pyridazinone compounds and uses thereof (2024-06-18),

7. 11091464 - Pyridazinone compounds and uses thereof (2021-08-17),

Edgewise Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for muscle diseases. The company leverages its proprietary platform to discover and develop treatments that target the underlying mechanisms of muscle disorders, with a particular emphasis on Duchenne muscular dystrophy (DMD) and other rare muscle diseases. Edgewise aims to improve the quality of life for patients by addressing unmet medical needs through its advanced drug development programs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

7 Patents

#141 in Boulder, CO

#835 in Colorado

#38,860 in US

Boulder, CO, United States of America

Edgewise Therapeutics, Inc.